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Conclusions: Incident analysis, task analyses, cognitive 
models and existing HRA databases have been used to build 
the qualitative taxonomic structure for the HRA method. 
These taxonomies are a first step to support the systematic 
analysis of potential errors and influencing factors.  
Next steps: 
Complete characterization of GTTs and PIFs using domain 
expert opinions and the adapted cognitive models. Develop 
the model for estimating error probabilities and test the HRA 
method to assess patient safety at a specific RT center.  
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Purpose/Objective: Dosimetric evaluation of comparative 
plans for a hypofractionated scheme of very low to 
intermediate risk cancer treatment (Grant AIRC - IG 13218), 
in order to define the treatment technique that obtains the 
best coverage of the target volume minimizing the dose to 
surrounding organs at risk (OARs). 
Materials and Methods: The CT and multiparametric MR 
scans of ten patients previously treated for prostate 
adenocarcinoma were used to identify the dominant 
intraprostatic lesion (DIL). Comparative treatment plans were 
obtained with three different techniques, namely Volumetric 
Modulated Arc Therapy (VMAT) obtained with Varian Eclipse 
for Trilogy, Intensity Modulated Radiation Therapy (IMRT) 
with BrainLab iPlan for VERO and proton-therapy (PT) with 
Syngo-TPS. The dosimetric scheme consists of five fractions 
with 7.25 Gy/fr for the prostate and a concomitant boost of 
7.5 or 9 Gy/fr for the DIL. The different prescription doses 
were tested on subgroups of five patients each, conveniently 
selected in order to obtain homogeneous groups in terms of 
DILs volume and position. The target coverage was 
considered a priority respect to the OARs constraints. DVH of 
target volumes and OARs and homogeneity (HI), conformity 
(CI) and gradient score (GSI) indexes were calculated and 
compared. Wilcoxon signed rank test was used to evaluate 
statistically significant differences among techniques. 
Results: Median values of target coverage and statistical 
analysis is shown in Table, with statistical significant 
differences highlighted. The less respected constraints are 
those related to posterior rectal wall and posterior anal canal 
wall, for which a maximum dose inferior to 16 Gy is required. 
In particular, for posterior anal canal wall the dose limit is 
exceeded in 9 out of 10 VMAT plans, 5/10 IMRT plans and 
3/10 PT plans. For posterior rectal wall, the dose limit is 
exceeded in 10/10 VMAT plans, 7/10 both IMRT and PT plans. 
The constraints for urethra (Dmax<40 Gy and V36Gy<50%) is also 
critical: the maximum dose is exceeded in 3/10 plans in each 
technique and the volumetric constraint is exceeded in 4/10 
VMAT plans, 10/10 IMRT plans and 8/10 PT plans. Overall, the 
90.3% and 86.9% of dosimetric constraints are fulfilled in 
plans with 7.5 and 9 Gy of boost doses, respectively. The 
analysed indexes are comparable among methods, with a 
slight superiority in homogeneity for VMAT plans and in 
gradient score for PT plans. 
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Conclusions: Preliminary results show an overall equivalence 
among different techniques in planning of hypofractionated 
prostatic treatments with concomitant boost. Further 
analysis will include time of treatments and NTCP 
calculation. In order to enrich the statistical analysis, plans 
with both boost doses will be realized on the complete 
patients cohort. Moreover, plans realized with CyberKnife 
will be also included in the analysis.  
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Purpose/Objective: Advances in radiotherapy (RT) offer 
better treatment options for patients. The evolving 
technology increases the complexity of the treatment 
process. The quality control mechanisms used in radiotherapy 
need to evolve appropriately. Widely publicised incidents 
such as those seen in New York, Glasgow and Epinal highlight 
the need to adapt to a more systematic approach to risk 
assessment in RT. The aviation, nuclear and chemical 
industries have been developing safety tools for decades. 
Failure Mode and Effects Analysis (FMEA) and Fault Tree 
Analysis (FTA) used in these industries have been suggested 
for RT. The novel methodology presented here integrates 
human error probability modelling with components of FMEA 
and FTA and applies them in a clinical setting. 
Materials and Methods: This proposed risk assessment 
method is a hybrid of current techniques. Graphical 
representation of the RT system demonstrates the 
relationship between tasks, equipment, software and users 
involved in the treatment process. Figure 1 shows part of the 
treatment delivery process and the relevant tasks. A 
modified version of the process described by Ford et al (Med 
Phys. 2012 Dec;39(12):7272-90) was used to evaluate the RT 
pathway. The components of each process were critically 
analysed to ascertain their fault potential. The baseline 
values from the Standardized Plant Analysis Risk-Human 
Reliability Analysis (SPAR-H) methodology (2005, NRC Report) 
were used to estimate human error probability. This model 
was applied to the RT pathway (from patient CT simulation to 
final treatment) for patients with prostate cancer. 
 
 
Fig. 1 Treatment delivery process and tasks involved 
 
Results: Twenty one error modes and eighteen safety 
barriers that could affect the patients’ treatment were 
identified. The remaining tasks were classified as (a) 
irrelevant to patient safety or (b) errors acting as a process 
inhibitor. In ideal human performance conditions this model 
estimated an incident rate of 0.17% (excluding commissioning 
of treatment units). These incidents refer to any unplanned 
deviation to standard treatment. The incident rate increases 
dramatically when performance shaping factors such as 
stress, available time, complexity etc are introduced into the 
system.  
Conclusions: This novel method of risk analysis is highly 
beneficial in evaluating the effectiveness of the safety 
system in place in RT. This model can be used to assess the 
propagation of errors and highlights the areas in the RT 
process that can be improved. The human error probability is 
an estimated value which can fluctuate under different 
conditions. The use of quantitative human errors values 
allows the utilisation of FTA mathematics. This risk 
assessment technique can be used to review new processes 
and their application within the system without 
compromising patient safety. This is a fluid model that can 
be constantly updated. 
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Purpose/Objective: To evaluate a newly-developed 
automatic system for detecting errors in the planning and 
delivery of radiotherapy. 
